Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair

This study has been completed.
Information provided by (Responsible Party):
Kaiser Permanente Identifier:
First received: September 24, 2007
Last updated: April 2, 2015
Last verified: April 2015
Results First Received: May 4, 2011  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Participant, Outcomes Assessor);   Primary Purpose: Treatment
Conditions: Cystocele
Uterine Prolapse
Urinary Incontinence
Interventions: Device: grafted anterior prolapse repair
Procedure: sutured anterior vaginal prolapse repair

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
Subjects were recruited from the Female Pelvic Medicine and Reconstructive Surgery Clinic at Kaiser Permanente Bellflower Medical Center between January 2005 and April 2006.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
Exclusion criteria were less than stage II anterior vaginal prolapse, current or future pregnancy, prior grafted anterior prolapse repair, impaired wound healing, known hypersensitivity to polypropylene, unable or unwilling to give valid informed consent or if scheduled to undergo concomitant Burch colposuspension or pubovaginal sling.

Reporting Groups
Anterior Colporrhaphy Anterior vaginal prolapse repair with anterior colporrhaphy (no graft)
Perigee Anterior vaginal prolapse repair with graft

Participant Flow:   Overall Study
    Anterior Colporrhaphy   Perigee
STARTED   38   38 
COMPLETED   33   33 

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Anterior Colporrhaphy Anterior vaginal prolapse repair with anterior colporrhaphy (no graft)
Perigee Anterior vaginal prolapse repair with graft
Total Total of all reporting groups

Baseline Measures
   Anterior Colporrhaphy   Perigee   Total 
Overall Participants Analyzed 
[Units: Participants]
 38   38   76 
[Units: Participants]
<=18 years   0   0   0 
Between 18 and 65 years   26   28   54 
>=65 years   12   10   22 
[Units: Years]
Mean (Standard Deviation)
 59  (9.5)   61  (10.5)   60  (10.5) 
[Units: Participants]
Female   38   38   76 
Male   0   0   0 
Region of Enrollment 
[Units: Participants]
United States   38   38   76 

  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Recurrent Stage II or Greater Anterior Vaginal Prolapse   [ Time Frame: three years ]

2.  Secondary:   Operative Time   [ Time Frame: perioperative ]

3.  Secondary:   Vaginal Mesh Exposure   [ Time Frame: perioperative ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
-Small number of subjects, Single surgeon, Medium follow-up, Limited ability to detect uncommon adverse events and small differences in quality of life and sexual symptom scores, Concurrent pelvic reconstructive and anti-incontinence procedures

  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact:  
Name/Title: John N. Nguyen, MD
Organization: SCPMG/Kaiser Permanente
phone: 562-657-2642

Publications automatically indexed to this study by Identifier (NCT Number):

Responsible Party: Kaiser Permanente Identifier: NCT00535301     History of Changes
Other Study ID Numbers: 4348
Study First Received: September 24, 2007
Results First Received: May 4, 2011
Last Updated: April 2, 2015